Screener
Mirum Pharmaceuticals, Inc. MIRM Professional service fees
Professional service fees at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Accrued sales deductions and other | $62,501 | $51,375 |
| Accrued compensation and related benefits | 28,389 | 47,276 |
| Accrued clinical trials | 22,872 | 13,959 |
| Accrued professional service fees | 21,886 | 17,292 |
| Accrued contract manufacturing and non-clinical costs | 17,670 | 8,721 |
| Accrued royalties payable | 16,204 | 16,208 |
| Operating lease liabilities, current | 2,405 | 2,139 |
| Accrued loss on firm purchase commitments | 2,107 | 2,107 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s professional service fees?
- Mirum Pharmaceuticals, Inc. (MIRM) reported professional service fees of $21.89M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s professional service fees changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s professional service fees increased by 56.1% year-over-year, from $14.02M to $21.89M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s professional service fees?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s professional service fees has grown at a 47.6% compound annual growth rate (CAGR), from $7.94M to $17.29M.
- What does professional service fees mean?
- Professional service fees
Ask your AI about Mirum Pharmaceuticals, Inc.'s professional service fees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude